Cargando…

Effect of infarct size on the risk of ventricular arrhythmias in patients with chronic total coronary occlusion

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: The presence of an untreated chronic total coronary occlusion (CTO) is associated with a higher risk of ventricular arrhythmias (VAs). This increased risk may be modulated by the presence of existing scar. We hypothesize that a lar...

Descripción completa

Detalles Bibliográficos
Autores principales: Hindi-Assaf, A, Van Der Graaf, M, Van Boven, N, Van Ettinger, M J B, Hoogendijk, M, Diletti, R, Szili-Torok, T, Theuns, D A M J, Yap, S C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207331/
http://dx.doi.org/10.1093/europace/euad122.259
_version_ 1785046429390077952
author Hindi-Assaf, A
Van Der Graaf, M
Van Boven, N
Van Ettinger, M J B
Hoogendijk, M
Diletti, R
Szili-Torok, T
Theuns, D A M J
Yap, S C
author_facet Hindi-Assaf, A
Van Der Graaf, M
Van Boven, N
Van Ettinger, M J B
Hoogendijk, M
Diletti, R
Szili-Torok, T
Theuns, D A M J
Yap, S C
author_sort Hindi-Assaf, A
collection PubMed
description FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: The presence of an untreated chronic total coronary occlusion (CTO) is associated with a higher risk of ventricular arrhythmias (VAs). This increased risk may be modulated by the presence of existing scar. We hypothesize that a larger scar size is associated with a higher risk of VA. OBJECTIVES: To evaluate whether infarct size is associated with VA in patients with an implantable cardioverter-defibrillator (ICD) and an untreated CTO. METHODS: In this retrospective study we included patients with an untreated CTO that received an ICD between 2005 and 2014. Infarct size was estimated using the Selvester QRS score on a baseline 12-lead ECG. The primary endpoint was any appropriate ICD therapy. RESULTS: Our study population comprised 148 patients (mean age at implantation 64 ± 10 years, 87% men) with an ICD and an untreated CTO. The median infarct size at baseline was 18% (IQR, 9-27%). Patients with a larger scar size (≥18%) more often had a CTO location in the LAD, higher proportion of LVEF <35%, and less hypertension and hypercholesterolemia compared to patients with a smaller infarct size (<18%). During a median follow-up of 35 months (interquartile range [IQR], 8-60 months), 42 patients (28%) received appropriate ICD therapy. The cumulative 5-year event rate was higher in the patients with a large infarct size (≥18%) in comparison to those with a smaller infarct size (<18%) (36% versus 19%, logrank P = 0.038, Figure). Multivariable Cox regression analysis demonstrated that a larger infarct size (≥18%) and a secondary prevention indication were independent factors associated with appropriate ICD therapy. The adjusted hazard ratio of large infarct size (≥18%) for appropriate ICD therapy was 2.34 (95% CI 1.20-4.58, p=0.01). CONCLUSION: In ICD recipients with an untreated CTO, a larger scar size is an independent factor associated with an increased risk of VA. [Figure: see text]
format Online
Article
Text
id pubmed-10207331
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-102073312023-05-25 Effect of infarct size on the risk of ventricular arrhythmias in patients with chronic total coronary occlusion Hindi-Assaf, A Van Der Graaf, M Van Boven, N Van Ettinger, M J B Hoogendijk, M Diletti, R Szili-Torok, T Theuns, D A M J Yap, S C Europace 13.1 - Pathophysiology and Mechanisms FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: The presence of an untreated chronic total coronary occlusion (CTO) is associated with a higher risk of ventricular arrhythmias (VAs). This increased risk may be modulated by the presence of existing scar. We hypothesize that a larger scar size is associated with a higher risk of VA. OBJECTIVES: To evaluate whether infarct size is associated with VA in patients with an implantable cardioverter-defibrillator (ICD) and an untreated CTO. METHODS: In this retrospective study we included patients with an untreated CTO that received an ICD between 2005 and 2014. Infarct size was estimated using the Selvester QRS score on a baseline 12-lead ECG. The primary endpoint was any appropriate ICD therapy. RESULTS: Our study population comprised 148 patients (mean age at implantation 64 ± 10 years, 87% men) with an ICD and an untreated CTO. The median infarct size at baseline was 18% (IQR, 9-27%). Patients with a larger scar size (≥18%) more often had a CTO location in the LAD, higher proportion of LVEF <35%, and less hypertension and hypercholesterolemia compared to patients with a smaller infarct size (<18%). During a median follow-up of 35 months (interquartile range [IQR], 8-60 months), 42 patients (28%) received appropriate ICD therapy. The cumulative 5-year event rate was higher in the patients with a large infarct size (≥18%) in comparison to those with a smaller infarct size (<18%) (36% versus 19%, logrank P = 0.038, Figure). Multivariable Cox regression analysis demonstrated that a larger infarct size (≥18%) and a secondary prevention indication were independent factors associated with appropriate ICD therapy. The adjusted hazard ratio of large infarct size (≥18%) for appropriate ICD therapy was 2.34 (95% CI 1.20-4.58, p=0.01). CONCLUSION: In ICD recipients with an untreated CTO, a larger scar size is an independent factor associated with an increased risk of VA. [Figure: see text] Oxford University Press 2023-05-24 /pmc/articles/PMC10207331/ http://dx.doi.org/10.1093/europace/euad122.259 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle 13.1 - Pathophysiology and Mechanisms
Hindi-Assaf, A
Van Der Graaf, M
Van Boven, N
Van Ettinger, M J B
Hoogendijk, M
Diletti, R
Szili-Torok, T
Theuns, D A M J
Yap, S C
Effect of infarct size on the risk of ventricular arrhythmias in patients with chronic total coronary occlusion
title Effect of infarct size on the risk of ventricular arrhythmias in patients with chronic total coronary occlusion
title_full Effect of infarct size on the risk of ventricular arrhythmias in patients with chronic total coronary occlusion
title_fullStr Effect of infarct size on the risk of ventricular arrhythmias in patients with chronic total coronary occlusion
title_full_unstemmed Effect of infarct size on the risk of ventricular arrhythmias in patients with chronic total coronary occlusion
title_short Effect of infarct size on the risk of ventricular arrhythmias in patients with chronic total coronary occlusion
title_sort effect of infarct size on the risk of ventricular arrhythmias in patients with chronic total coronary occlusion
topic 13.1 - Pathophysiology and Mechanisms
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207331/
http://dx.doi.org/10.1093/europace/euad122.259
work_keys_str_mv AT hindiassafa effectofinfarctsizeontheriskofventriculararrhythmiasinpatientswithchronictotalcoronaryocclusion
AT vandergraafm effectofinfarctsizeontheriskofventriculararrhythmiasinpatientswithchronictotalcoronaryocclusion
AT vanbovenn effectofinfarctsizeontheriskofventriculararrhythmiasinpatientswithchronictotalcoronaryocclusion
AT vanettingermjb effectofinfarctsizeontheriskofventriculararrhythmiasinpatientswithchronictotalcoronaryocclusion
AT hoogendijkm effectofinfarctsizeontheriskofventriculararrhythmiasinpatientswithchronictotalcoronaryocclusion
AT dilettir effectofinfarctsizeontheriskofventriculararrhythmiasinpatientswithchronictotalcoronaryocclusion
AT szilitorokt effectofinfarctsizeontheriskofventriculararrhythmiasinpatientswithchronictotalcoronaryocclusion
AT theunsdamj effectofinfarctsizeontheriskofventriculararrhythmiasinpatientswithchronictotalcoronaryocclusion
AT yapsc effectofinfarctsizeontheriskofventriculararrhythmiasinpatientswithchronictotalcoronaryocclusion